CURNA, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 8980
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 64191
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 3960
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 19106
 
  
 
C07K PEPTIDES 3133
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 3203
 
  
 
A61L METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES 170
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 148
 
  
 
G06F ELECTRIC DIGITAL DATA PROCESSING 1446

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0002,696 TREATMENT OF SODIUM CHANNEL, VOLTAGE-GATED, ALPHA SUBUNIT (SCNA) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO SCNAAug 29, 17Jan 04, 18[A61K, C12Q, C12N]
2017/0355,990 TREATMENT OF SODIUM CHANNEL, VOLTAGE-GATED, ALPHA SUBUNIT (SCNA) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO SCNAAug 29, 17Dec 14, 17[A61K, C12Q, C12N]
2017/0226,516 TREATMENT OF GLIAL CELL DERIVED NEUROTROPHIC FACTOR (GDNF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO GDNFMay 04, 15Aug 10, 17[C12Q, C12N]
2016/0340,678 TREATMENT OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO VEGFAug 05, 16Nov 24, 16[A61K, C12Q, C12N]
2016/0273,037 TREATMENT OF COLONY-STIMULATING FACTOR 3 (CSF3) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENE TRANSCRIPT TO CSF3Jun 07, 16Sep 22, 16[C12Q, C12N, G01N]
2016/0168,568 TREATMENT OF ADIPONECTIN (ADIPOQ) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO AN ADIPONECTIN (ADIPOQ)Feb 23, 16Jun 16, 16[C12Q, C12N]
2016/0168,574 TREATMENT OF INSULIN GENE (INS) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO AN INSULIN GENE (INS)Dec 02, 15Jun 16, 16[C12Q, C12N, G06F]
2016/0046,942 TREATMENT OF SEX HORMONE BINDING GLOBULIN (SHBG) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO SHBGOct 26, 15Feb 18, 16[C12N]
2015/0368,644 TREATMENT OF INTERFERON-RELATED DEVELOPMENTAL REGULATOR 1 (IFRD1) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO IFRD1Sep 10, 15Dec 24, 15[C12N]
2015/0284,724 TREATMENT OF SIRTUIN (SIRT) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO A SIRTUIN (SIRT)Jun 16, 15Oct 08, 15[C12N]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9920322 Treatment of vascular endothelial growth factor (VEGF) related diseases by inhibition of natural antisense transcript to VEGFAug 05, 16Mar 20, 18[A61K, C12Q, C12N]
9920369 Treatment of colony-stimulating factor 3 (CSF3) related diseases by inhibition of natural antisene transcript to CSF3Jun 07, 16Mar 20, 18[C07H, C12Q, C12N, G01N]
9914923 Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factorJan 01, 15Mar 13, 18[A61K, C07H, C12N]
9909126 Treatment of Adiponectin (ADIPOQ) related diseases by inhibition of natural antisense transcript to an Adiponectin (ADIPOQ)Feb 23, 16Mar 06, 18[A61K, C12Q, C12N]
9902958 Treatment of discs large homolog (DLG) related diseases by inhibition of natural antisense transcript to DLGJun 07, 16Feb 27, 18[A61K, C12Q, C12N]
9902959 Treatment of Frataxin (FXN) related diseases by inhibition of natural antisense transcript to FXNFeb 02, 17Feb 27, 18[A61K, C07H, C12Q, C12N]
9902995 Treatment of pyrroline-5-carboxylate reductase 1 (PYCR1) related disease by inhibition of natural antisense transcript to PYCR1Jun 07, 16Feb 27, 18[A61K, C12Q, C12N]
9879256 Treatment of hepatocyte growth factor (HGF) related diseases by inhibition of natural antisense transcript to HGFDec 10, 14Jan 30, 18[C12Q, C12N]
9879264 Treatment of membrane bound transcription factor peptidase, site 1 (MBTPS1) related diseases by inhibition of natural antisense transcript to MBTPS1Sep 17, 15Jan 30, 18[A61K, C12N]
9873873 Treatment of alpha-L-iduronidase (IDUA) related diseases by inhibition of natural antisense transcript to IDUAOct 28, 15Jan 23, 18[A61K, C12N, G01N]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0031,750 TREATMENT OF BRAIN DERIVED NEUROTROPHIC FACTOR (BDNF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO BDNFAbandonedMar 12, 13Jan 29, 15[C12N]
2013/0210,893 TREATMENT OF INTERFERON-RELATED DEVELOPMENTAL REGULATOR 1 (IFRD1) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO IFRD1AbandonedOct 26, 11Aug 15, 13[C07H]
2013/0137,751 TREATMENT OF GLIAL CELL DERIVED NEUROTROPHIC FACTOR (GDNF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO GDNFAbandonedFeb 05, 13May 30, 13[C12Q, C12N]
2012/0295,952 TREATMENT OF FILAGGRIN (FLG) RELATED DISEASES BY MODULATION OF FLG EXPRESSION AND ACTIVITYAbandonedSep 24, 10Nov 22, 12[A61K, C12N, G01N, A61P]
2012/0289,583 TREATMENT OF INSULIN RECEPTOR SUBSTRATE 2 (IRS2) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO IRS2 AND TRANSCRIPTION FACTOR E3 (TFE3)AbandonedDec 30, 10Nov 15, 12[A61K, C07H, C12N, G01N, A61P]
2012/0252,869 TREATMENT OF SIRTUIN (SIRT) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO A SIRTUIN (SIRT)AbandonedJul 23, 10Oct 04, 12[A61K, C07H, C12N, A61P, C07K]
2012/0171,170 TREATMENT OF COLLAGEN GENE RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO A COLLAGEN GENEAbandonedJun 16, 10Jul 05, 12[A61K, C07H, C12N, G01N, A61P, C07K]
2012/0046,236 TREATMENT OF TRISTETRAPROLINE (TTP) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO TTPAbandonedMay 06, 10Feb 23, 12[A61K, C07H, C12Q, C12N, G01N, A61P, C07K]
2011/0319,317 TREATMENT OF SIRTUIN 1 (SIRT1) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO SIRT1AbandonedMar 03, 10Dec 29, 11[A61K, C07H, C12Q, C12N, A61P, A61Q]
2011/0319,476 TREATMENT OF GLIAL CELL DERIVED NEUROTROPHIC FACTOR (GDNF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO GDNFAbandonedFeb 12, 10Dec 29, 11[A61K, C07H, C12Q, C12N, G01N, A61P]
2011/0294,870 TREATMENT OF TUMOR SUPPRESSOR GENE RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO THE GENEAbandonedDec 03, 09Dec 01, 11[A61K, C07H, C12N, G01N, A61P]
2011/0237,649 TREATMENT OF SIRTUIN 1 (SIRT1) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO SIRTUIN 1AbandonedDec 02, 09Sep 29, 11[A61K, C07H, C12N, G01N, A61P]

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.